+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antifungal Drug"

From
Candidiasis - Pipeline Insight, 2025 - Product Thumbnail Image

Candidiasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Invasive Aspergillosis - Pipeline Insight, 2025 - Product Thumbnail Image

Invasive Aspergillosis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Chronic Pulmonary Infections- Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Pulmonary Infections- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Aspergillosis - Pipeline Insight, 2025 - Product Thumbnail Image

Aspergillosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Otomycosis - Pipeline Insight, 2025 - Product Thumbnail Image

Otomycosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Chagas Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Chagas Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
From
Ketoconazole - Global Strategic Business Report - Product Thumbnail Image

Ketoconazole - Global Strategic Business Report

  • Report
  • September 2025
  • 274 Pages
  • Global
From
From
Meningitis Treatment - Global Strategic Business Report - Product Thumbnail Image

Meningitis Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 458 Pages
  • Global
From
Candidiasis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Candidiasis Therapeutics - Global Strategic Business Report

  • Report
  • September 2025
  • 474 Pages
  • Global
From
Oropharyngeal Candidiasis - Global Strategic Business Report - Product Thumbnail Image

Oropharyngeal Candidiasis - Global Strategic Business Report

  • Report
  • September 2025
  • 462 Pages
  • Global
From
Cryptococcosis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Cryptococcosis Therapeutics - Global Strategic Business Report

  • Report
  • September 2025
  • 473 Pages
  • Global
From
Aspergillosis Treatment - Global Strategic Business Report - Product Thumbnail Image

Aspergillosis Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 374 Pages
  • Global
From
Caspofungin - Global Strategic Business Report - Product Thumbnail Image

Caspofungin - Global Strategic Business Report

  • Report
  • September 2025
  • 279 Pages
  • Global
From
Aspergillosis Drugs - Global Strategic Business Report - Product Thumbnail Image

Aspergillosis Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 373 Pages
  • Global
From
Candidiasis Drugs - Global Strategic Business Report - Product Thumbnail Image

Candidiasis Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Loading Indicator

The Antifungal Drug market is a subset of the larger Infectious Diseases Drugs market. Antifungal drugs are used to treat fungal infections, which can range from mild to life-threatening. These drugs work by either killing the fungus or preventing its growth. Common antifungal drugs include azoles, polyenes, and echinocandins. Azoles are the most commonly prescribed antifungal drugs, and are used to treat a wide range of fungal infections. Polyenes are used to treat more serious fungal infections, while echinocandins are used to treat severe fungal infections. The Antifungal Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, Novartis, GlaxoSmithKline, and AstraZeneca. Other companies in the market include Bayer, Sanofi, Allergan, and Johnson & Johnson. Show Less Read more